132 related articles for article (PubMed ID: 1869367)
1. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
Mezö G; Szekerke M; Sármay G; Gergely J
Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives.
Biondi L; Filira F; Rocchi R; Tzehoval E; Fridkin M
Int J Pept Protein Res; 1993 Jan; 41(1):43-51. PubMed ID: 8436445
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of glycosylated tuftsins and tuftsin-containing IgG fragment undecapeptide.
Biondi L; Filira F; Gobbo M; Scolaro B; Rocchi R
Int J Pept Protein Res; 1991 Feb; 37(2):112-21. PubMed ID: 2019473
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
Buchta R; Fridkin M; Pontet M; Romeo D
Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
[TBL] [Abstract][Full Text] [Related]
8. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
9. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
Martinez J; Winternitz F
Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
[TBL] [Abstract][Full Text] [Related]
10. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
[TBL] [Abstract][Full Text] [Related]
12. Competition between tuftsin and HBV S-protein sequences.
Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
[TBL] [Abstract][Full Text] [Related]
13. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
Nishioka K; Obeyesekere NU; McMurray JS
Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
[TBL] [Abstract][Full Text] [Related]
14. 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
Gershonov E; Granoth R; Tzehoval E; Gaoni Y; Fridkin M
J Med Chem; 1996 Nov; 39(24):4833-43. PubMed ID: 8941397
[TBL] [Abstract][Full Text] [Related]
15. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
16. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
[TBL] [Abstract][Full Text] [Related]
18. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory potential of hydrophobic analogs of Rigin and their role in providing protection against Plasmodium berghei infection in mice.
Dutta RC; Puri A; Anand N
Int Immunopharmacol; 2001 May; 1(5):843-55. PubMed ID: 11379040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
